ENGLEWOOD, Colo., December 11, 2024--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities.

Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of significant growth and innovation milestones. Prior to his tenure as CEO, he served as CFO, COO and as President, Emerging Technologies. Mr. Demski has significant public company board experience, having served as a member of Globus Medical’s board from its inception through April 2022, and currently serving as a member of the board of directors of Alphatec Spine (NASDAQ: ATEC) since October 2023 and having previously served on the board of Axonics, Inc. from January 2021 until its acquisition by Boston Scientific in November 2024 Mr. Demski received a B.S. in Business Administration from the University of Michigan and an M.B.A. from Stanford Graduate School of Business.

"I am thrilled to welcome Dave to our Board of Directors during this pivotal time," says Albert DaCosta, Chairman and CEO of Paragon 28. "His extensive industry knowledge, leadership experience and operational expertise will be invaluable to Paragon 28 as we continue to advance our mission of improving foot and ankle patient outcomes."

"I am honored to join the Board of Directors at Paragon 28 and to contribute to the company’s incredible mission of transforming the foot and ankle market," says Dave Demski, newly appointed director for Paragon 28. "I look forward to collaborating with the Board and the Company’s leadership team to continue driving innovation and impacting lives of patients suffering from foot and ankle conditions around the world."

About Paragon 28, Inc.

Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.